Filing Summary
XORTX Therapeutics Inc. filed a Form 6-K as a foreign private issuer for October 2026, dated October 8, 2026. The filing identifies the company’s principal office as Calgary, Alberta, Canada, and indicates it files annual reports on Form 20-F.
Business Context and Reporting Period
This filing is a report of a news release dated October 8, 2026 (Exhibit 99.1). The news release itself is not included in the provided filing text, so its subject and details cannot be summarized.
Financial Metrics and Changes
The provided text contains no revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating or financial metrics. It also does not provide comparable-period results or explain material changes.
Outlook, Risks, and Unusual Items
No outlook, management commentary, risks, contingencies, or unusual items are described in the provided text.
Important Facts to Verify
- Obtain and review Exhibit 99.1, the October 8, 2026 news release; its contents are absent from the supplied text.
- Verify whether the referenced news release contains financial information, guidance, material developments, or risk disclosures.